The WISH 2.0 Intervention for Irritable Bowel Syndrome: Protocol for a Pilot Randomized Controlled Trial
Authors:
- Elizabeth N MadvaEMElizabeth N Madva
- Jeff C HuffmanJHJeff C Huffman
- Helen Burton-MurrayHBHelen Burton-Murray
- Emmett McGranaghanEMEmmett McGranaghan
- Megan BidgoodMBMegan Bidgood
- Jenny Y GanJGJenny Y Gan
- Benjamin WassermanBWBenjamin Wasserman
- Emily H FeigEFEmily H Feig
- Brian HealyBHBrian Healy
- Kyle StallerKSKyle Staller
- Bonney ReedBRBonney Reed
- Roberta ScloccoRSRoberta Sclocco
Open Access
- 23 July 2026
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e98352
Abstract
Background: There is a critical need for acceptable, scalable, and mechanistically targeted behavioral health interventions for irritable bowel syndrome (IBS), known as brain-gut behavior therapies (BGBTs). Although positive psychology (PP) interventions, which focus on the cultivation of positive psychological well-being, have been linked to improved health outcomes across diverse medical populations, they have not yet been investigated in IBS. To address this gap, we developed WISH (Well-Being in IBS: Strengths and Happiness), a novel, 9-week, phone-delivered PP-based BGBT for individuals with IBS. Objective: This randomized controlled trial (RCT) aims to evaluate the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of a 9-week phone-delivered PP intervention for IBS compared with a time- and attention-matched educational control. Methods: The WISH 2.0 trial is a parallel-group, 9-week pilot RCT that aims to enroll 50 adults meeting Rome IV criteria for IBS. Participants are randomized (1:1), stratified by IBS subtype and gender, to either the WISH 2.0 intervention or an educational control condition. Both conditions consist of 9 weekly 30-minute phone sessions accompanied by weekly manualized exercises. Primary outcomes are feasibility (proportion completing ≥6 of 9 sessions) and acceptability (weekly ease and utility ratings). Secondary outcomes include WISH 2.0’s preliminary effects on health-related, health behavior, and psychological outcomes, assessed at 4 time points: baseline, intervention midpoint, the postintervention assessment, and the 3-month postintervention assessment. Candidate gut-brain mechanisms that might underlie WISH 2.0’s effects, including changes in autonomic function (heart rate variability), interoception (self-report measure), gene expression (whole transcriptome RNA sequencing), and immune system activity (serum inflammatory biomarkers), will be explored before and after the intervention. Results: The trial was approved by the Mass General Brigham Institutional Review Board and prospectively registered at ClinicalTrials.gov in March 2025. Funding was awarded in June 2025. Following a study start-up period, recruitment commenced in October 2025 and is ongoing. As of July 2026, 20 participants have been enrolled. Study completion is anticipated in August 2028. Conclusions: This trial will determine the feasibility and acceptability of WISH 2.0, a novel PP intervention for IBS. Comparative results between WISH 2.0 and an educational control, including the possibility of equivalent outcomes, will provide important mechanistic insights and facilitate further optimization of BGBTs for IBS, informing a future fully powered efficacy trial.Keywords
This publication has 105 references indexed in Scilit:
- Effects of Positive Psychology Interventions on Inflammatory Biomarkers and Cortisol: A Systematic Review and Meta-AnalysisInternational Journal of Applied Positive Psychology, 2025
- A Randomized Controlled Neuroimaging Trial of Cognitive Behavioral Therapy for Fibromyalgia PainArthritis & Rheumatology, 2023
- Irritable bowel syndrome: Factors of importance for disease‐specific quality of lifeUnited European Gastroenterology Journal, 2022
- Behavioral Clinical Trials for Chronic Diseases2021
- Association of Optimism With Cardiovascular Events and All-Cause MortalityJAMA Network Open, 2019
- The influence of interoceptive awareness on functional connectivity in patients with irritable bowel syndromeBrain Imaging and Behavior, 2016
- A Positive Psychology Intervention for Patients with an Acute Coronary Syndrome: Treatment Development and Proof-of-Concept TrialJournal of Happiness Studies, 2015
- Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndromeQuality of Life Research, 2011
- Gender-related traits, quality of life, and psychological adjustment among women with irritable bowel syndromeQuality of Life Research, 2009
- Orientations to happiness and life satisfaction: the full life versus the empty lifeJournal of Happiness Studies, 2005